Blood based biomarkers beyond genomics for lung cancer screening

被引：38
|
作者：
Hanash, Samir M. [1 ]
Ostrin, Edwin Justin [2 ]
Fahrmann, Johannes F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2018年 / 7卷 / 03期
关键词：
Biomarkers; proteins; metabolites; autoantibodies; RISK PREDICTION MODEL; DOSE COMPUTED-TOMOGRAPHY; SERUM BIOMARKER; EARLY-DIAGNOSIS; PANEL; VALIDATION; PLASMA; ADENOCARCINOMA; IDENTIFICATION; METABOLOMICS;
D O I：
10.21037/tlcr.2018.05.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
While there is considerable interest at the present time in the development of so-called liquid biopsy approaches for cancer detection based notably on circulating tumor DNA, there are other types of potential biomarkers that show promise for lung cancer screening and early detection. Here we review approaches and some of the promising markers based on proteomics, metabolomics and the immune response to tumor antigens in the form of autoantibodies.
引用
收藏
页码：327 / 335
页数：9
相关论文
共 50 条
  • [1] Lung cancer biomarkers: Beyond Genomics
    Robles, Ana I.
    ONCOGENE, 2019, 38 : 9 - 10
  • [2] Cancer genomics-based screening of new therapeutic targets and biomarkers for lung cancer
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Genomics-based screening of novel therapeutic targets and biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers
    von Itzstein, Mitchell S.
    Gerber, David E.
    Minna, John D.
    CANCER RESEARCH, 2021, 81 (13) : 3441 - 3443
  • [5] Serum and blood based biomarkers for lung cancer screening: a systematic review
    Chu, Gavin C. W.
    Lazare, Kim
    Sullivan, Frank
    BMC CANCER, 2018, 18
  • [6] Serum and blood based biomarkers for lung cancer screening: a systematic review
    Gavin C. W. Chu
    Kim Lazare
    Frank Sullivan
    BMC Cancer, 18
  • [7] Comprehensive cancer genomics-based screening of new therapeutic targets and biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Comprehensive genomics-based screening of novel therapeutic targets and biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Emerging Strategies in Lung Cancer Screening: Blood and Beyond
    Bhalla, Sheena
    Yi, Sofia
    Gerber, David E.
    CLINICAL CHEMISTRY, 2024, 70 (01) : 60 - 67
  • [10] Lung Cancer Screening Initiative and Identification of Novel Blood Biomarkers for Early Detection of Lung Cancer
    Deb, S.
    Kuckovic, A.
    Anderson, A.
    Berei, J.
    Sreenivasappa, S.
    Ross, J.
    Martell, S.
    Vitali, C.
    Schulz, W.
    Racherla, K. S.
    Puri, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1147 - S1148
12345